Silobreaker.com    Log In
   My Page    Help   
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 21, 2009 4:47 PM

Published 10/23/2009 by FinanzNachrichten.de


BRIEF-US FDA confirms 23 PML infection cases with Elan, Biogen MS drug

WASHINGTON, Oct 23 (Reuters) - U.S. Food and Drug Administration spokeswoman Sandy Walsh on Friday said:

* there have been 23 confirmed cases of progressive multifocal leukoencephalopathy (PML), a potentially fatal brain infection, in patients

treated with Elan, Biogen drug tysabri for multiple...

Share this 

What others report on the same story

Elan shares fall by 20pc as drug-linked disease...
Shares in Elan plunged 20pc to ?3.42 in Dublin yesterday after its multiple sclerosis treatment Tysabri was linked to over 20 cases of a potentially fatal brain ... - [10/24/2009 - Irish Independent]
Biogen shares tumble on more MS drug-linked inf...
Biogen Idecs shares are down over five percent today, following reports that the number of cases of a rare but often deadly brain infection in patients taking multiple ... - [10/24/2009 - Mass High Tech]
Bucyrus Tops Estimates By Wide Margin
MEMC Electronic Materials Inc. (NYSE: WFR) blamed plunging sales for swinging to a third quarter loss of 29 cents per share compared with income of 80 cents per ... - [10/23/2009 - San Francisco Chronicle]
EU Panel Reviewing Biogen, Elan's Tysabri; Cite... - [10/23/2009 - Nasdaq]
Europe to review risk of Biogen/Elan drug Tysabri - [10/23/2009 - Interactive Investor International]
Europe to review risk of Biogen/Elan drug Tysabri - [10/23/2009 - Reuters UK]
UPDATE 1-Biogen, Elan shares plummet on new Tys... - [10/23/2009 - Reuters UK]
Elan (ELN) and Biogen (BIIB) Weak On Jump In Ty... - [10/23/2009 - Street Insider]
Elan shares drop on Tysabri review - [10/23/2009 - Irish Times]
Biogen Shares Drop as Tysabri PML Cases Climb t... - [10/23/2009 - Xconomy]
1 2

Related Stories

First Reported 10/30/2009 - Updated 10/30/2009 - 3 Documents (in Health)
Procter & Gamble Co - Click to view image in its original context
Procter & Gamble Co
P&G Warned By FDA On Vicks Combination Drugs - Update
(RTTNews) - Friday, U.S. Food and Drug Administration sent a warning letter to Procter & Gamble Co. (PG: News ) notifying that its products Vicks DayQuil Plus Vitamin C and Vicks Nyquil Plus Vitamin C are illegally marketed combinations of drug ingredients ... [RTTNews.com - 10/30/2009]
First Reported 10/22/2009 - Updated 10/23/2009 - 3 Documents (in Medicine)
Phony Online Flu Cures Draw FDA Ire
The US Food and Drug Administration (FDA) is monitoring the online marketing and sale of products that claim to diagnose, prevent, treat or cure the H1N1 influenza virus - and in at least one high-profile case - is ordering the well-established brand, ... [MarketingVOX - 10/23/2009]
First Reported 10/23/2009 - Updated 10/24/2009 - 3 Documents (in Health)
Food and Drug Administration - Click to view 360-page
Food and Drug Administration
FDA is back in business
Paying attention to thinking about consumers again? What a crazy idea!The Smart Choices nutrition labeling program, created voluntarily by nine large U.S. manufacturers, is halting after federal regulators said such systems could mislead consumers, officials ... [AMERICAblog News| A great nation deserves the t ... - 10/24/2009]
First Reported 10/26/2009 - Updated 10/26/2009 - 1 Documents (in Health)
FDA sticks by Shire exclusivity decision
Business Financial Newswire - The US FDA has confirmed its decision to grant Shire five-year market exclusivity for its Vyvanse attention-deficit hyperactivity disorder treatment, following a legal challenge from a rival.The FDA had ruled Vyvanse qualified ... [Business Financial Newswire - 10/26/2009]
First Reported 10/27/2009 - Updated 10/27/2009 - 1 Documents (in Health)
FDA approves chronic lymphocytic leukemia treatment
ROCKVILLE,$ Md. (Oct. 27) The Food and Drug Administration has approved a new treatment for a cancer that mostly affects the elderly.The FDA announced the approval of GlaxoSmithKline’s Arzerra (ofatumumab) for the treatment of chronic lymphocytic leukemia, ... [Drug Store News - 10/27/2009]
First Reported 10/27/2009 - Updated 10/27/2009 - 1 Documents (in New Business)
Smart Choices Responds to FDA Concerns
Labeling program is put on hold for the time being.A group of U.S. manufacturers voluntarily launched a food labeling program this year to highlight foods meeting certain nutritional standards with a special label on the front of packaging. But the Food ... [Southern Farmer - 10/27/2009]
First Reported 10/28/2009 - Updated 10/28/2009 - 1 Documents (in Health)
FDA Panel Backs Novel Device To Treat Severe Asthma
WASHINGTON -(Dow Jones)- A Food and Drug Administration panel recommended Wednesday that the agency approve a first-of-kind device to treat severe asthma patients.The device--the Alair Bronchial Thermoplasty System--if approved would be the first non-drug ... [Nasdaq - 10/28/2009]
First Reported 10/22/2009 - Updated 10/22/2009 - 1 Documents (in Biology)
Elan focuses on boosting MS drug sales after selling stake to J&J
Kelly Martin, chief executive of Elan, said the Irish drugs group would focus on increasing sales of its multiple sclerosis drug Tysabri, following the sale of a stake... ... [FT.com - Health - 10/22/2009]
First Reported 10/16/2009 - Updated 10/16/2009 - 10 Documents (in Health)
US watchdog warns of bogus H1N1 drugs
AFPThe US Food and Drug Administration (FDA) has warned consumers to avoid buying medicines online to treat swine flu, saying one such product contained nothing more than talc and over-the-counter fever-reducer.The FDA raised the warning after some of ... [The Age - 10/16/2009]
First Reported 10/16/2009 - Updated 10/16/2009 - 2 Documents (in Health)
Acorda gets positive FDA review for MS drug
Acorda Therapeutics said the Food and Drug Administration (FDA) Peripheral and Central Nervous System Drugs (PCNSD) Advisory Committee has approved its multiple sclerosis (MS) drug after it demonstrated substantial evidence of effectiveness as a treatment ... [Bio Spectrum Asia - 10/16/2009]
First Reported 10/19/2009 - Updated 10/20/2009 - 3 Documents (in Health)
FDA delays approval for Amgen's osteoporosis drug
The Food and Drug Administration has delayed approval of a new osteoporosis drug from Amgen Inc., the Thousand Oaks biotech company announced Monday.The company received a letter concerning the approval of denosumab, which will be sold under the name ... [Individual.com - 10/20/2009]
First Reported 10/21/2009 - Updated 10/21/2009 - 2 Documents (in Health)
WATCH: FDA Takes On Cereal Food Labels
Government takes aim at products that appear to mislead on nutrition. ... [ABC News - 10/21/2009]
In Focus
Network

Blogs

sort by: Date | Relevance
Harnessing The Full Potential Of A Common MS Th... [Scientific Blogging - 10/16/2009]
While inflammation often causes damage to the nerves of multiple sclerosis (MS) patients, a group of HBI researchers has been studying how neuroinflammation can ...
When FDA Fails to Follow-Up On Rapid Drug Appro... [WSJ.com: Health Blog - 10/26/2009]
Here’s a reasonable idea: Create an accelerated process to approve new, potentially life-saving drugs — and build in post-approval requirements to make sure the ...
I Will Present Survey Results at November FDA H... [Pharma Marketing Blog - 10/18/2009]
I just received confirmation from Jean-Ah Kang, Special Assistant to Tom Abrams at DDMAC in charge of Web 2.0 policy development, that I will be presenting the results ...
Harnessing the Full Potential of a Common MS Th... [Scientific Blogging - Neuroscience - 10/16/2009]
While inflammation often causes damage to the nerves of multiple sclerosis (MS) patients, a group of HBI researchers has been studying how neuroinflammation can ...
FDA is back in business [AMERICAblog News| A great nation deserves the t ... - 10/24/2009]
Paying attention to thinking about consumers again? What a crazy idea!The Smart Choices nutrition labeling program, created voluntarily by nine large U.S. manufacturers, ...
1 2 3 4 5 6 7 8

Audio/Video

sort by: Date | Relevance
FDA Approves MICARDIS® (Telmisartan) [Mefeedia Video Tag : biotechnolo - 10/19/2009]
FDA Approves MICARDIS® (Telmisartan) [Mefeedia Video Tag : biotechnolo - 10/19/2009]
1

  •  
  •  
  •